Back to Market Feed

Product Information

EDARBI 40 MG TABLET is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $8.2828 per EA under NDC 60631004030. Its NADAC has been published 613 times since Nov 26, 2014.

FDA first approved this application on Feb 25, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

EDARBI 40 MG TABLET

Azilsartan kamedoxomil
$8.2828per EA

Strength

40 mg/1

NDC

60631004030

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

AZILSARTAN KAMEDOXOMIL

Approval Type

New Drug (NDA)

FDA Application

NDA200796

FDA Approved

2/25/2011

TE Code

AB

On Market Since

2/1/2013

Pharmacological Classes

Angiotensin 2 Receptor Blocker
Angiotensin 2 Type 1 Receptor Antagonists
Decreased Blood Pressure

Price Statistics

The NADAC for EDARBI 40 MG TABLET has been published 613 times since Nov 26, 2014, and over the history we have for it it has risen 106.6%. The table below summarizes its recorded NADAC range and movement.

Current price$8.2828 per EA
All-time high$8.3010 (Sep 10, 2025)
All-time low$4.0087 (Nov 26, 2014)
52-week high$8.3010
52-week low$8.2828
Median price$6.2771
Average price$6.3656
Largest weekly change+10.0% (Feb 11, 2015)
Weeks tracked613
Tracking sinceNov 26, 2014

Price History

1W

-0.1%

1M

-0.1%

3M

-0.1%

6M

-0.1%

1Y

-0.2%

3Y

+20.0%

5Y

+28.1%

All

+106.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Azilsartan kamedoxomil market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

COZAAR 25 MG TABLET
Brand
78206012101•Organon LLC
$3.3500
per EA
MICARDIS HCT 80-25 MG TABLET
Brand
00597004237•Boehringer Ingelheim Pharmaceuticals Inc.
$4.4768
per EA
EPANED 1 MG/ML ORAL SOLUTION
Brand
52652400101•Azurity Pharmaceuticals Inc.
$4.4785
per ML
MICARDIS HCT 80-12.5 MG TABLET
Brand
00597004437•Boehringer Ingelheim Pharmaceuticals Inc.
$4.4802
per EA
MICARDIS 80 MG TABLET
Brand
00597004137•Boehringer Ingelheim Pharmaceuticals Inc.
$4.4823
per EA
MICARDIS HCT 40-12.5 MG TABLET
Brand
00597004337•Boehringer Ingelheim Pharmaceuticals Inc.
$4.4836
per EA
COZAAR 50 MG TABLET
Brand
78206012201•Organon LLC
$4.4943
per EA
COZAAR 50 MG TABLET
Brand
78206012202•Organon LLC
$4.4943
per EA
MICARDIS 40 MG TABLET
Brand
00597004037•Boehringer Ingelheim Pharmaceuticals Inc.
$4.5019
per EA
HYZAAR 50-12.5 TABLET
Brand
78206013901•Organon LLC
$5.0084
per EA

Frequently asked questions

What is the NADAC price of EDARBI 40 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for EDARBI 40 MG TABLET, manufactured by Azurity Pharmaceuticals Inc., is $8.2828 per EA (NDC 60631004030), effective Aug 19, 2026.

How has the price of EDARBI 40 MG TABLET changed over time?

Over the history we have for it, the NADAC for EDARBI 40 MG TABLET has risen 106.6%. It has been tracked across 613 weekly CMS publications since Nov 26, 2014.

What are the highest and lowest recorded NADAC prices for EDARBI 40 MG TABLET?

Since Nov 26, 2014, the NADAC for EDARBI 40 MG TABLET has ranged from a low of $4.0087 (Nov 26, 2014) to a high of $8.3010 (Sep 10, 2025), with a median of $6.2771 per EA.

Are there cheaper alternatives to EDARBI 40 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of EDARBI 40 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures EDARBI 40 MG TABLET?

EDARBI 40 MG TABLET (NDC 60631004030) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.